Latest News and Decisions

12 March 2020

At the meeting of 12 February 2020 the RMA:

Determined New Statements of Principles (SOPs) for:

Condition SOPs
chronic multisymptom illness 3/2020 4/2020
acute pancreatitis 5/2020 6/2020
hypersensitivity pneumonitis 7/2020 8/2020
malignant neoplasm of the nasopharynx 9/2020 10/2020
multiple sclerosis 11/2020 12/2020
osteonecrosis 13/2020 14/2020

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
migraine 15/2020 16/2020
acute myeloid leukaemia 17/2020
malignant neoplasm of the lung 18/2020
malignant neoplasm of the eye 19/2020 20/2020

Determined to revoke and not reissue Statements of Principles (SOPs) for:

Condition SOPs
dysbaric osteonecrosis 17/2015 18/2015

Note:

  • The investigation concerning 'extrinsic allergic alveolitis' has resulted in the determination of Statements of Principles concerning hypersensitivity pneumonitis.
  • The investigation concerning osteonecrosis, including dysbaric osteonecrosis, has resulted in the determination of Statements of Principles concerning osteonecrosis and the repeal of SOPs concerning dysbaric osteonecrosis. Dysbaric osteonecrosis is now included in the Statements of Principles concerning osteonecrosis.

The above SOPs and Revocations take effect from 23 March 2020.

Summary of Changes

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
diabetes mellitus Intention to remove one or more factors June 2020
retinal vascular occlusive disease Intention to remove one or more factors June 2020

Finalised Declarations for:

Condition Declaration Reasons for Decision
acute myeloid leukaemia
malignant neoplasm of the lung

Completed Investigations

The above determinations, declarations and revocations conclude the previously advertised investigations into:

The above declaration notices appear in the Government Notices Gazette of 11 March 2020.